1. Home
  2. IMAB vs COOK Comparison

IMAB vs COOK Comparison

Compare IMAB & COOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • COOK
  • Stock Information
  • Founded
  • IMAB 2014
  • COOK 1985
  • Country
  • IMAB United States
  • COOK United States
  • Employees
  • IMAB N/A
  • COOK N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • COOK Wholesale Distributors
  • Sector
  • IMAB Health Care
  • COOK Consumer Discretionary
  • Exchange
  • IMAB Nasdaq
  • COOK Nasdaq
  • Market Cap
  • IMAB 200.9M
  • COOK 209.0M
  • IPO Year
  • IMAB 2020
  • COOK 2021
  • Fundamental
  • Price
  • IMAB $4.87
  • COOK $1.32
  • Analyst Decision
  • IMAB Strong Buy
  • COOK Hold
  • Analyst Count
  • IMAB 3
  • COOK 7
  • Target Price
  • IMAB $6.33
  • COOK $2.07
  • AVG Volume (30 Days)
  • IMAB 4.2M
  • COOK 287.5K
  • Earning Date
  • IMAB 05-15-2025
  • COOK 08-06-2025
  • Dividend Yield
  • IMAB N/A
  • COOK N/A
  • EPS Growth
  • IMAB N/A
  • COOK N/A
  • EPS
  • IMAB N/A
  • COOK N/A
  • Revenue
  • IMAB N/A
  • COOK $579,453,000.00
  • Revenue This Year
  • IMAB N/A
  • COOK $0.06
  • Revenue Next Year
  • IMAB N/A
  • COOK $3.18
  • P/E Ratio
  • IMAB N/A
  • COOK N/A
  • Revenue Growth
  • IMAB N/A
  • COOK N/A
  • 52 Week Low
  • IMAB $0.60
  • COOK $1.28
  • 52 Week High
  • IMAB $5.90
  • COOK $3.97
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 75.47
  • COOK 32.15
  • Support Level
  • IMAB $3.30
  • COOK $1.34
  • Resistance Level
  • IMAB $3.94
  • COOK $1.76
  • Average True Range (ATR)
  • IMAB 0.58
  • COOK 0.08
  • MACD
  • IMAB 0.23
  • COOK -0.04
  • Stochastic Oscillator
  • IMAB 76.12
  • COOK 6.31

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About COOK Traeger Inc.

Traeger Inc designs, sources, sells, and supports wood pellet fueled barbeque grills sold to retailers, distributors, and direct to consumers. It produces and sells the pellets used to fire the grills and also sells Traeger-branded rubs, spices, and sauces, as well as grilling accessories including covers, barbeque tools, trays, liners, and merchandise. The company's geographical segments include North America and the Rest of the world, of which majority of revenue is from North America.

Share on Social Networks: